Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Accel-Heal at a glance ® commissioners What is Accel-Heal? Accel-Heal is a certified and patented, electroceutical treatment device (Class IIA) designed to improve and accelerate healing rates in patients with complex wounds. What is an electroceutical? Practically all of the body’s organs and functions are regulated through neural circuits communicating via electrical impulses, it is therefore possible to interpret the electrical language of disease from the level of gene expression upwards. By extension, it is then possible to stimulate, inhibit or change a malfunctioning pathway in order to correct the defect. The new term for this innovative area of medicine is electroceutical. Unlike the universal term previously used, ‘e-stim’, electroceutical implies a more accurately targeted application more akin to its pharmaceutical equivalent. Synapse – Accel-Heal’s parent company is leading the way in this area of medicine with the development of a clinically relevant electroceutical with its patented Synapse Sequence found within the compact Class IIA device Accel-Heal. What is Accel-Heal used for? Accel-Heal is to be used to treat any complex wound alongside standard care. How long is the treatment? Accel-Heal is a 12 day treatment course, consisting of six pre programmed, battery powered 48 hour single use units, applied consecutively. How big is Accel-Heal? Accel-Heal is much smaller and portable than any other available treatment device (7cm x 4cm x 2cm). How does Accel-Heal work? Neural circuits communicating via electrical impulses regulate many physiological functions, therefore it is possible to interpret the electrical language of health and disease from the level of gene expression upwards. It is now possible to inhibit or change a malfunctioning electrical pathway in order to correct a potential defect. Accel-Heal is a non invasive, compact Class IIA medical device which uses the patented Synapse Sequence programmed to deliver a specific series of electric energy interactions through the skin to manipulate gene expression to modify specific physiological functions in dermal tissue. Why should I commission the purchase of Accel-Heal? With more emphasis on outcomes based commissioning, requiring commissioners and clinicians to deliver better outcomes at lower costs Accel-Heal helps as it improves and accelerates positive outcomes for patients with complex wounds, while significantly contributing to cost savings: 95% clinical efficacy cost per QALY of minus £7,696* 27% reduction in nurse visits *QALY is a unit of ‘treatment’ cost being a measure of disease burden including both the quality and quantity of life lived. Each drug or treatment is considered on a case-by-case basis. Generally, if a treatment costs more than £20,000-30,000 per QALY, then it would not be considered to be cost effective. A treatment with a minus cost per QALY figure saves both money and improves the patient outcome over and above the current treatment or drug. Why should clinicians use Accel-Heal? At Synapse – the home of Accel-Heal we know that every wound has the potential to become complex. Accel-Heal brings clinicians a tool to heal wounds before they become complex, as well as a long awaited breakthrough to healing those that have already become non-healing. Reducing the impact of wounds on patients through accelerating healing, reducing pain and exudate, Accel-Heal also reduces costs for wound care providers by cutting down healing times and resources such as nursing visits, dressings and analgesia. With a 95% clinical efficacy recorded in clinical trials, developed to provide ease and simplicity of clinical application Accel-Heal improves and accelerates healing rates, while significantly contributing to cost savings with its cost per QALY of minus £7,696 (reduction of 15% to NHS costs) and a 27% reduction in nurse visits. How to use Accel-Heal? Each Accel-Heal treatment course consists of six, battery powered 48 hour single use units (to be applied consecutively) and electrodes pads. The pads should be applied to healthy skin either side of the wound and then connected to the Accel-Heal unit, during a standard care procedure (dressing change). The unit is then activated using an on / off switch, tucked into the external dressing, and left to work for 48 hours. Once the 48 hour dose of treatment has finished, the unit will automatically turn itself off. A new unit is then attached to the electrodes, with the used unit disposed of safely. The effectiveness of Accel-Heal 100% 75% 57% 50% 38% 25% 5% 0% Healed Improved 0% Worsened No change >95% efficacy recorded in clinical trials >38% complete healing rate recorded for Accel-Heal versus only 9% for compression bandaging alone >27% reduction in nurse visits, 15% reduction in treatment costs and a cost per QALY of minus £7,696 Find out more To find out more about Accel-Heal visit www.accelheal.com To find out more about Synapse – The home of Accel-Heal visit www.synapseelectroceutical.com Arrange an educational visit To arrange a non promotional visit to find out more about Accel-Heal, email us on [email protected] or call us on 01959 569 433 Purchase Accel-Heal Please contact us at [email protected] or call us on 01959 569 433 NHS Supply Chain Accel-Heal is available via NHS Supply Chain and SBS Services, Product Code: K560-6 Synapse Electroceutical Ltd 1 Churchill Court, Hortons Way, Westerham, Kent, TN16 1BT t: 01959 569 433 e:[email protected] www.synapseelectroceutical.com Company reg.no: 04626631